Business Standard

A COMMERCIAL FEATURE

What's this ?

Commercial Feature is a Business Standard Digital Marketing Initiative.

The Editorial/Content team at Business Standard has not contributed to writing or editing these articles.

For further information, please write to assist@bsmail.in

Natco receives US FDA approval for generic budesonide capsule

Budesonide capsule (enteric coated) is a gastroenterology medicine used for treating patients with mild to moderate Crohn's disease

BS B2B Bureau  |  Hyderabad 

Natco receives US FDA approval for generic budesonide capsule

Pharma Limited on Thursday announced that it has received final approval from the US Food and Drug Administration (FDA) for version of capsule (enteric coated) 3 mg. and its marketing partner Alvogen plan to launch this product in the US immediately.

The approved product is the version of Perrigo Pharma’s EC capsule. According to IMS Health, EC capsule (3 mg) and its versions had US sales of approximately $ 370 million for twelve months ending December 2015.

is a gastroenterology medicine used for treating patients with mild to moderate Crohn's disease.

RECOMMENDED FOR YOU

Natco receives US FDA approval for generic budesonide capsule

Budesonide capsule (enteric coated) is a gastroenterology medicine used for treating patients with mild to moderate Crohn's disease

Budesonide capsule (enteric coated) is a gastroenterology medicine used for treating patients with mild to moderate Crohn's disease
Pharma Limited on Thursday announced that it has received final approval from the US Food and Drug Administration (FDA) for version of capsule (enteric coated) 3 mg. and its marketing partner Alvogen plan to launch this product in the US immediately.

The approved product is the version of Perrigo Pharma’s EC capsule. According to IMS Health, EC capsule (3 mg) and its versions had US sales of approximately $ 370 million for twelve months ending December 2015.

is a gastroenterology medicine used for treating patients with mild to moderate Crohn's disease.

image
Business Standard
177 22

Natco receives US FDA approval for generic budesonide capsule

Budesonide capsule (enteric coated) is a gastroenterology medicine used for treating patients with mild to moderate Crohn's disease

Pharma Limited on Thursday announced that it has received final approval from the US Food and Drug Administration (FDA) for version of capsule (enteric coated) 3 mg. and its marketing partner Alvogen plan to launch this product in the US immediately.

The approved product is the version of Perrigo Pharma’s EC capsule. According to IMS Health, EC capsule (3 mg) and its versions had US sales of approximately $ 370 million for twelve months ending December 2015.

is a gastroenterology medicine used for treating patients with mild to moderate Crohn's disease.

image
Business Standard
177 22